These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8307195)

  • 1. Effects of calcium ions on proteolytic processing of HIV-1 gp160 precursor and on cell fusion.
    Moulard M; Montagnier L; Bahraoui E
    FEBS Lett; 1994 Feb; 338(3):281-4. PubMed ID: 8307195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
    Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
    Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
    Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
    J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1.
    Gu M; Rappaport J; Leppla SH
    FEBS Lett; 1995 May; 365(1):95-7. PubMed ID: 7774724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E; Jones IM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM).
    Decroly E; Vandenbranden M; Ruysschaert JM; Cogniaux J; Jacob GS; Howard SC; Marshall G; Kompelli A; Basak A; Jean F
    J Biol Chem; 1994 Apr; 269(16):12240-7. PubMed ID: 8163529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor.
    Gabuzda D; Olshevsky U; Bertani P; Haseltine WA; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):34-40. PubMed ID: 1984054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T4-lymphocyte endoprotease responsible for the proteolytic processing of HIV-1 gp160, like Kex2p endoprotease, is a calcium-dependent enzyme.
    Moulard M; Achstetter T; Ikehara Y; Bahraoui E
    Biochimie; 1994; 76(3-4):251-6. PubMed ID: 7819331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing and routage of HIV glycoproteins by furin to the cell surface.
    Moulard M; Hallenberger S; Garten W; Klenk HD
    Virus Res; 1999 Mar; 60(1):55-65. PubMed ID: 10225274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing protease for gp160 human immunodeficiency virus type I envelope glycoprotein precursor in human T4+ lymphocytes. Purification and characterization.
    Kido H; Kamoshita K; Fukutomi A; Katunuma N
    J Biol Chem; 1993 Jun; 268(18):13406-13. PubMed ID: 8099909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
    Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
    Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
    Willey RL; Maldarelli F; Martin MA; Strebel K
    J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage.
    Fenouillet E; Gluckman JC
    Virology; 1992 Apr; 187(2):825-8. PubMed ID: 1372142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoproteolytic cleavage of HIV-1 gp160 envelope precursor occurs after exit from the trans-Golgi network (TGN).
    Kantanen ML; Leinikki P; Kuismanen E
    Arch Virol; 1995; 140(8):1441-9. PubMed ID: 7661695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing.
    Owens RJ; Compans RW
    Virology; 1990 Dec; 179(2):827-33. PubMed ID: 2238472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
    Ashorn P; Berger EA; Moss B
    Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.